{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:30:07Z","timestamp":1790127007943,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.01.040","type":"journal-article","created":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T13:00:18Z","timestamp":1422190818000},"page":"1267-1273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: Application to emerging infectious diseases"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-1632","authenticated-orcid":false,"given":"Patricio","family":"Oyarzun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faviel F.","family":"Gonzalez-Galarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3548-268X","authenticated-orcid":false,"given":"Mikael","family":"Boden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-9166","authenticated-orcid":false,"given":"Bostjan","family":"Kobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.01.040_bib0270","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases","volume":"430","author":"Morens","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0280","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0285","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.287.5452.443","article-title":"Emerging infectious diseases of wildlife \u2013 threats to biodiversity and human health","volume":"287","author":"Daszak","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0290","doi-asserted-by":"crossref","first-page":"e11072","DOI":"10.1371\/journal.pone.0011072","article-title":"A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules","volume":"5","author":"Ribeiro","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0295","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00005-010-0067-0","article-title":"CD4+ T cell epitope discovery and rational vaccine design","volume":"58","author":"Rosa","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0300","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/omi.2012.0022","article-title":"A critical appraisal of techniques, software packages, and standards for quantitative proteomic analysis","volume":"16","author":"Gonzalez-Galarza","year":"2012","journal-title":"Omics"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0305","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.vaccine.2011.11.002","article-title":"HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX((R)) B\/E","volume":"30","author":"Paris","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cellimm.2007.02.005","article-title":"A systematic bioinformatics approach for selection of epitope-based vaccine targets","volume":"244","author":"Khan","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0315","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0952-7915(98)80124-6","article-title":"HLA supertypes and supermotifs: a functional perspective on HLA polymorphism","volume":"10","author":"Sette","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002510050594","article-title":"Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism","volume":"50","author":"Sette","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0325","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/bioinformatics\/btm471","article-title":"Modeling the adaptive immune system: predictions and simulations","volume":"23","author":"Lundegaard","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0330","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/eji.200838632","article-title":"Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype","volume":"38","author":"Hillen","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0335","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.4049\/jimmunol.174.11.7085","article-title":"In silico identification of supertypes for class II MHCs","volume":"174","author":"Doytchinova","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0340","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"Greenbaum","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0345","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00251-012-0665-6","article-title":"Consensus classification of human leukocyte antigen class II proteins","volume":"65","author":"Saha","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/icb.2010.65","article-title":"Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses","volume":"89","author":"Sirskyj","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0355","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1254\/jphs.CR0070056","article-title":"Prediction of T-cell epitope","volume":"105","author":"Tsurui","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0360","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2105-14-52","article-title":"PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity","volume":"14","author":"Oyarzun","year":"2013","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0365","doi-asserted-by":"crossref","first-page":"e30483","DOI":"10.1371\/journal.pone.0030483","article-title":"TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0370","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00251-013-0720-y","article-title":"NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ","volume":"65","author":"Karosiene","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0375","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1471-2105-11-482","article-title":"MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes","volume":"11","author":"Bordner","year":"2010","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0380","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1073\/pnas.0134224100","article-title":"Structural basis and prediction of substrate specificity in protein serine\/threonine kinases","volume":"100","author":"Brinkworth","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0385","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2174\/156802612802652439","article-title":"Computational modelling of linear motif-mediated protein interactions","volume":"12","author":"Kobe","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0390","series-title":"HIV molecular immunology database","author":"Korber","year":"1995"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0395","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0400","doi-asserted-by":"crossref","first-page":"e5013","DOI":"10.1371\/journal.pone.0005013","article-title":"Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection","volume":"4","author":"Ramduth","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0405","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1128\/JVI.78.9.4463-4477.2004","article-title":"Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides","volume":"78","author":"Kaufmann","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0410","doi-asserted-by":"crossref","first-page":"e1000780","DOI":"10.1371\/journal.ppat.1000780","article-title":"HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity","volume":"6","author":"Vingert","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0415","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/eji.200838759","article-title":"Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia","volume":"38","author":"Ondondo","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0420","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.gene.6363797","article-title":"Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa","volume":"2","author":"Luoni","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0425","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1128\/JVI.00008-06","article-title":"Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins","volume":"80","author":"Eschli","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0430","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for Lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0435","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0440","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rmv.329","article-title":"Towards a human Lassa fever vaccine","volume":"11","author":"Fisher-Hoch","year":"2001","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0445","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/JVI.68.12.8056-8063.1994","article-title":"CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection","volume":"68","author":"Matloubian","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0450","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4049\/jimmunol.174.2.614","article-title":"Cutting edge: MHC class II-restricted killing in vivo during viral infection","volume":"174","author":"Jellison","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0455","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2003.12.013","article-title":"Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones","volume":"321","author":"Meulen","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0460","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1128\/JVI.01619-06","article-title":"Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine","volume":"80","author":"Mungall","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0465","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2008.05.016","article-title":"A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats","volume":"26","author":"McEachern","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0470","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1016\/j.vaccine.2011.06.015","article-title":"A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge","volume":"29","author":"Pallister","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0475","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1128\/JVI.79.11.6690-6702.2005","article-title":"Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus","volume":"79","author":"Bossart","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0480","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/JVI.80.4.1972-1978.2006","article-title":"Antibody prophylaxis and therapy against Nipah virus infection in hamsters","volume":"80","author":"Guillaume","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0485","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1074\/jbc.M807469200","article-title":"A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F)","volume":"284","author":"Aguilar","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0490","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.80.2.891-899.2006","article-title":"Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies","volume":"80","author":"Zhu","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0495","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1073\/pnas.1201586109","article-title":"Promiscuous binding of extracellular peptides to cell surface class I MHC protein","volume":"109","author":"Eisen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0500","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.4049\/jimmunol.181.5.3039","article-title":"Immunodominance of CD4T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design","volume":"181","author":"Weaver","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0505","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0510","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/iji.12030","article-title":"16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles","volume":"40","author":"Gonzalez-Galarza","year":"2013","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0515","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-0039.2009.01361.x","article-title":"A bioinformatics approach to ascertaining the rarity of HLA alleles","volume":"74","author":"Middleton","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0520","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0525","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.01.040_bib0530","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1099\/vir.0.81218-0","article-title":"Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus","volume":"86","author":"White","year":"2005","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T20:32:53Z","timestamp":1717705973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X15000845"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: Application to emerging infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}